Study details
Enrolling now
Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
St. Jude Children's Research Hospital
NCT IDNCT04195347ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1/2
Target enrollment
42
Study length
about 8.4 years
Ages
≤21
Locations
2 sites in NC, TN
What this study is about
This trial is testing a treatment called CM4620 in adults with acute pancreatitis caused by asparaginase. The goal is to see if CM4620 can reduce the severity of pancreatitis and prevent complications like pseudocyst or necrotizing pancreatitis.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take CM4620
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.